These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24568822)

  • 21. Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials.
    Naccarella F; Naccarelli GV; Maranga SS; Lepera G; Grippo MC; Melandri F; Gatti M; Pazzaglia S; Spinelli G; Angelini V; Ambrosioni E; Borghi C; Giovagnorio MT; Nisam S
    Curr Opin Cardiol; 2002 Jan; 17(1):6-18. PubMed ID: 11790928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension and concurrent arrhythmias.
    Lombardi F; Terranova P
    Curr Pharm Des; 2003; 9(21):1703-13. PubMed ID: 12871203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sudden death: ACE inhibitors and beta-blockers.
    Landray MJ
    Basic Res Cardiol; 2000; 95 Suppl 1():I37-40. PubMed ID: 11192351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure].
    Mundhenke M
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2297-8; author reply 2298. PubMed ID: 17036279
    [No Abstract]   [Full Text] [Related]  

  • 26. Heart failure as a substrate and trigger for ventricular tachycardia.
    Alvarez CK; Cronin E; Baker WL; Kluger J
    J Interv Card Electrophysiol; 2019 Dec; 56(3):229-247. PubMed ID: 31598875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Severe ventricular arrhythmias in a patient with dilated cardiomyopathy and automated implantable defibrillator (AID)].
    Ikama SM; Makani J; Ellenga-Mbolla B; Ondze-Kafata LI; Gombet TR; Kimbally-Kaky G
    Pan Afr Med J; 2017; 27():31. PubMed ID: 28761607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-myocardial infarction trials: beta blockers, antiarrhythmics, thrombolytics.
    Anderson JL
    Control Clin Trials; 1996 Jun; 17(3 Suppl):17S-27S. PubMed ID: 8877264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-arrhythmic therapy of ventricular tachyarrhythmias and sudden cardiac death after acute myocardial infarction.
    Schweitzer P
    Vnitr Lek; 2006 Dec; 52(12):1185-9. PubMed ID: 17299912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Arterial hypertension and cardiac arrhythmias].
    Vester EG
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-blockers and amiodarone for the primary prevention of sudden cardiac death.
    Frankenberger O; Steinberg JS
    Curr Cardiol Rep; 1999 Nov; 1(4):274-81. PubMed ID: 10980854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmic risk stratification of post-myocardial infarction patients.
    Naccarella F; Lepera G; Rolli A
    Curr Opin Cardiol; 2000 Jan; 15(1):1-6. PubMed ID: 10666655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure.
    Packer M
    JACC Heart Fail; 2019 Oct; 7(10):902-906. PubMed ID: 31521684
    [No Abstract]   [Full Text] [Related]  

  • 36. Prediction and prevention of sudden cardiac death in heart failure.
    Lane RE; Cowie MR; Chow AW
    Heart; 2005 May; 91(5):674-80. PubMed ID: 15831662
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.
    Hallstrom AP; Wyse DG; McAnulty J; ;
    J Interv Card Electrophysiol; 2008 Dec; 23(3):159-66. PubMed ID: 18810620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
    Kanopskiĭ SG; Staritskiĭ AG; Bozhko AA
    Kardiologiia; 2004; 44(10):13-8. PubMed ID: 15477784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sudden death in ischemic heart disease - 2017.
    Buxton AE
    Int J Cardiol; 2017 Jun; 237():64-66. PubMed ID: 28365181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.